Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus.
Kountouras
Jannis
J
Chatzopoulos
Dimitrios
D
Zavos
Christos
C
D000230:Adenocarcinoma / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology; D017209:Apoptosis / Q000235:genetics; D001471:Barrett Esophagus / Q000150:complications / Q000382:microbiology*; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000453:epidemiology / Q000382:microbiology* / Q000473:pathology; D005755:Gastrins / Q000378:metabolism; D005764:Gastroesophageal Reflux / Q000150:complications / Q000382:microbiology*; D005786:Gene Expression Regulation; D016481:Helicobacter Infections / Q000378:metabolism / Q000382:microbiology; D016480:Helicobacter pylori; D006801:Humans; D015994:Incidence; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D008954:Models, Biological; D016328:NF-kappa B / Q000096:biosynthesis; D009363:Neoplasm Proteins / Q000378:metabolism; D015995:Prevalence; D000077022:Survivin; D051025:bcl-Associated Death Protein / Q000235:genetics / Q000378:metabolism
C107489:BIRC5 protein, human; D005755:Gastrins; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D016328:NF-kappa B; D009363:Neoplasm Proteins; D000077022:Survivin; D051025:bcl-Associated Death Protein; D051546:Cyclooxygenase 2